MktsMarkets

Gossamer Bio, Inc.
NASDAQ: GOSSKey statistics
GOSS News
Stories mentioning GOSS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 16,955 | 13,799 | 13,294 | 11,489 | 9,889 | 9,379 | 9,480 | 95,842 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 61,821 | 59,838 | 62,408 | 50,254 | 46,699 | 45,507 | 43,399 | 43,755 |
| Operating Income (Loss) | (44,866) | (46,039) | (49,114) | (38,765) | (36,810) | (36,128) | (33,919) | 52,087 |
| Interest Income | 354.00 | 447.00 | 687.00 | 542.00 | 294.00 | (744.00) | 430.00 | 1,749 |
| Interest Expense | ||||||||
| Other Expense | 603.00 | 1,017 | 2,954 | 2,694 | 2,624 | 4,171 | 4,288 | 2,747 |
| Pretax Income | (48,221) | (38,273) | (31,935) | 53,667 | ||||
| Tax Provision | 0.00 | 0.00 | (1,132) | 4,435 | ||||
| Net Income (Loss) | (46,664) | (47,238) | (48,221) | (38,273) | (36,638) | (33,029) | (30,803) | 49,232 |
| Earnings Per Share (Basic) | (0.20) | (0.21) | (0.21) | (0.17) | (0.16) | (0.15) | (0.14) | 0.22 |
| Earnings Per Share (Diluted) | (0.20) | (0.21) | (0.21) | (0.17) | (0.16) | (0.15) | (0.14) | 0.22 |
| Weighted Average Shares Outstanding (Basic) | 234,137 | 228,519 | 227,981 | 227,275 | 226,818 | 226,228 | 226,346 | 226,221 |
| Weighted Average Shares Outstanding (Diluted) | 234,137 | 228,519 | 227,981 | 227,275 | 226,818 | 226,228 | 226,346 | 238,543 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GOSS
Gossamer Bio, Inc. (NASDAQ: GOSS) is a stock listed on the Nasdaq Stock Market under the ticker symbol GOSS. It last traded at $10.38 (Oct 30, 2026, 4:00 PM ET), down 2.9% on the day. That gives Gossamer Bio a market capitalisation of $63.4M.
Over the past 52 weeks GOSS has traded between $8.29 and $309.60.
Revenue for the quarter ended Mar 31, 2026 was $17.0M; a net loss of $46.7M. Revenue was up 71.5% from $9.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $17.0M | -$46.7M | -275.2% |
| Dec 31, 2025 | $13.8M | -$47.2M | -342.3% |
| Sep 30, 2025 | $13.3M | -$48.2M | -362.7% |
| Jun 30, 2025 | $11.5M | -$38.3M | -333.1% |
From Gossamer Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…